Jeremy Curnock-Cook
Follow
Get notifications in MyBN when activity occurs.
Upgrade your subscription to use this feature.
Jeremy Curnock-Cook
Lists and Charts
Total Shareholder Return as at 29/11/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 353rd | Bioxyne | 40% | 2% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Bioxyne | $9.6m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Non-Executive Director |  | 2010 - 2014 | |
| Non-Executive Director | | - |
Directors Interests
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| Avita Medical | 07 Jun 2024 | Other | 6,175 | OtherConversion of securities: 9,200 RSU | ||
| Avita Medical | 07 Jun 2024 | Issued | 6,175 | OtherConversion of securities | ||
| Avita Medical | 06 Jun 2024 | Issued | 3,943 | OtherIssue of options | ||
| Avita Medical | 06 Jun 2024 | Issued | 9,200 | OtherIssue of securities: 15,375 RSU | ||
| Avita Medical | 22 Dec 2023 | Sold | 2,500 | $12.05 | $30,121 | OtherAs advised by the company: Sale of Common Stock to satisfy personal taxobligations in relation to the vesting of RSUsin December 2023. |
Powered by Morningstar ®
